HOME >> BIOLOGY >> NEWS
Long-distance command sends human growth hormone into action

(Philadelphia, PA) -- Scientists have long sought to determine what agent controls the production of the human growth hormone hGH, which is vital for proper physical development.

Now, in findings that point toward an eventual gene therapy for the type of dwarfism that results when the pituitary gland is unable to manufacture the hormone, scientists at the University of Pennsylvania School of Medicine have found the mechanism that sets hGH in action. In addition, they've discerned an unusual pattern of activation in which the key mechanism operates by remote control. Their research will appear in the Friday, February 15, issue of the journal Molecular Cell. Working with transgenic mice, the Penn researchers were able to pinpoint the activation mechanism at location called hypersensitive site 1 (HS1), within the "locus control region" 15 kilobases from the hGH gene. A kilobase is a measurement representing a unit of nucleic acid. Within the microscopic realm of cells, this activation is the equivalent of unlocking the front door of a house from seven buildings away. "What we found is surprising because most genes are controlled by a promoter element adjacent to the gene, or within the gene's proximity. But in the case of this human growth hormone, the controlling mechanism is so far away there is an intervening gene between hGH and the activation site," said Stephen Liebhaber, MD, Professor of Genetics and Medicine. He is corresponding author for the study along with Nancy Cooke, MD, Professor of Medicine in the Division of Endocrinology, Diabetes and Metabolism.

The human gene cluster containing hGH includes five separate human growth genes, four of which have importance during fetal development. Only the gene hGH functions following birth, and is necessary for normal growth: Without it, humans develop a condition called pituitary dwarfism, in which their physical stature never reaches five feet.

Liebhaber, Cooke and their colleagues at Pen
'"/>

Contact: Ellen O'Brien
ellen.obrien@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
14-Feb-2002


Page: 1 2

Related biology news :

1. Backstage with a command performer
2. Researcher is using natures command and control network to develop ways to engineer organisms
3. One gene found to command many others to build a wing
4. Genetic master switch sends bacteria toward seafood dinner
5. ITA to AMA: Taxing tanning sends wrong health message to teens
6. Planet Vearth sends out call for help
7. Montana drought sends paleontologists to field early for largest project in states history
8. Climate change plus human pressure caused large mammal extinctions in late Pleistocene
9. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
10. Most recent common ancestor of all living humans surprisingly recent
11. Wildlife Conservation Society hosts public symposium on human-wildlife diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Biology News(10 mins):
(Date:9/17/2017)... ... 17, 2017 , ... GeneOne Life Science, Inc. announces that ... Safety (KMFDS) for an Investigational New Drug application for a Phase I/IIa study ... The study in Korea represents the second clinical trial for GLS-5300. , ...
(Date:9/14/2017)... ... September 14, 2017 , ... Boston Strategic ... experience with Health Economics and Outcomes Research (HEOR) and ‘big data’ to provide ... 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. ...
(Date:9/13/2017)... ... 13, 2017 , ... AMRI, a global contract research, development ... and quality of life for more than 25 years, today announced that John ... the International Standards Organization/Technical Committee 194: Biological and Clinical Evaluation of Medical ...
(Date:9/12/2017)... (PRWEB) , ... September 12, 2017 , ... It wasn’t ... months, it has been hot, hot, hot, as Lajollacooks4u has had a record-breaking number ... , Guests came from far and wide to celebrate company outings, family get-togethers, anniversaries ...
Breaking Biology Technology:
Cached News: